GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update

October 31, 2022

https://www.globenewswire.com/news-release/2022/10/31/2545030/0/en/GT-Biopharma-Reports-Third-Quarter-Fiscal-2022-Financial-Results-and-Business-Update.html

BRISBANE, CALIFORNIA, Oct. 31, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ:GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company’s proprietary natural killer (NK) cell engager, TriKE® platform, today announced third quarter fiscal 2022 results for the period ended September 30, 2022.

Read more at globenewswire.com

Related news for (GTBP)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.